The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Over the Counter (OTC) Drugs & Dietary Supplements Market Research Report 2025

Global Over the Counter (OTC) Drugs & Dietary Supplements Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1426247

No of Pages : 102

Ask Your Query

Synopsis

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements.

The global Over the Counter (OTC) Drugs & Dietary Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Over the Counter (OTC) Drugs & Dietary Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over the Counter (OTC) Drugs & Dietary Supplements.

Report Scope

The Over the Counter (OTC) Drugs & Dietary Supplements market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Over the Counter (OTC) Drugs & Dietary Supplements market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Over the Counter (OTC) Drugs & Dietary Supplements companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Pfizer Inc.
  • Novartis International AG
  • Roche Holding AG
  • Merck & Co., Inc.
  • Sanofi S.A
  • Johnson & Johnson
  • Gilead Sciences
  • GlaxoSmithKline plc.
  • Bayer Healthcare AG
  • AstraZeneca plc.
  • Alacer Corp.
  • Alcon Inc.
  • Alfresa Pharma Corporation
  • Alkalon A/S
  • Alliance Healthcare
  • Allergan, Plc.
  • Reckitt Benckiser Plc.
  • Bausch & Lomb
  • AbbVie Inc.
  • The Colgate-Palmolive Company

Segment by Type

  • Analgesic & Pain Relievers
  • Dermatological Products
  • Cough, Cold, and Flu Products
  • Vitamin Supplements
  • Mineral Supplements
  • Ophthalmic Products

Segment by Application

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacy
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Over the Counter (OTC) Drugs & Dietary Supplements companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Analgesic & Pain Relievers
1.2.3 Dermatological Products
1.2.4 Cough, Cold, and Flu Products
1.2.5 Vitamin Supplements
1.2.6 Mineral Supplements
1.2.7 Ophthalmic Products
1.3 Market by Application
1.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Perspective (2019-2030)
2.2 Over the Counter (OTC) Drugs & Dietary Supplements Growth Trends by Region
2.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Region (2019-2024)
2.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2025-2030)
2.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics
2.3.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends
2.3.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
2.3.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
2.3.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue
3.1.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue (2019-2024)
3.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Players (2019-2024)
3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Over the Counter (OTC) Drugs & Dietary Supplements Revenue
3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio
3.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2023
3.5 Over the Counter (OTC) Drugs & Dietary Supplements Key Players Head office and Area Served
3.6 Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service
3.7 Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Type
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Type (2019-2024)
4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2025-2030)
5 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Application
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Application (2019-2024)
5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)
6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024)
6.4 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)
7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024)
7.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)
8.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2019-2024)
8.4 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)
9.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024)
9.4 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)
10.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024)
10.4 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Detail
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.1.4 Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.1.5 Pfizer Inc. Recent Development
11.2 Novartis International AG
11.2.1 Novartis International AG Company Detail
11.2.2 Novartis International AG Business Overview
11.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.2.4 Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.2.5 Novartis International AG Recent Development
11.3 Roche Holding AG
11.3.1 Roche Holding AG Company Detail
11.3.2 Roche Holding AG Business Overview
11.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.3.4 Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.3.5 Roche Holding AG Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Detail
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.4.4 Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.4.5 Merck & Co., Inc. Recent Development
11.5 Sanofi S.A
11.5.1 Sanofi S.A Company Detail
11.5.2 Sanofi S.A Business Overview
11.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.5.4 Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.5.5 Sanofi S.A Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.6.4 Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Detail
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.7.4 Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.7.5 Gilead Sciences Recent Development
11.8 GlaxoSmithKline plc.
11.8.1 GlaxoSmithKline plc. Company Detail
11.8.2 GlaxoSmithKline plc. Business Overview
11.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.8.4 GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.8.5 GlaxoSmithKline plc. Recent Development
11.9 Bayer Healthcare AG
11.9.1 Bayer Healthcare AG Company Detail
11.9.2 Bayer Healthcare AG Business Overview
11.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.9.4 Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.9.5 Bayer Healthcare AG Recent Development
11.10 AstraZeneca plc.
11.10.1 AstraZeneca plc. Company Detail
11.10.2 AstraZeneca plc. Business Overview
11.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.10.4 AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.10.5 AstraZeneca plc. Recent Development
11.11 Alacer Corp.
11.11.1 Alacer Corp. Company Detail
11.11.2 Alacer Corp. Business Overview
11.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.11.4 Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.11.5 Alacer Corp. Recent Development
11.12 Alcon Inc.
11.12.1 Alcon Inc. Company Detail
11.12.2 Alcon Inc. Business Overview
11.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.12.4 Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.12.5 Alcon Inc. Recent Development
11.13 Alfresa Pharma Corporation
11.13.1 Alfresa Pharma Corporation Company Detail
11.13.2 Alfresa Pharma Corporation Business Overview
11.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.13.4 Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.13.5 Alfresa Pharma Corporation Recent Development
11.14 Alkalon A/S
11.14.1 Alkalon A/S Company Detail
11.14.2 Alkalon A/S Business Overview
11.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.14.4 Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.14.5 Alkalon A/S Recent Development
11.15 Alliance Healthcare
11.15.1 Alliance Healthcare Company Detail
11.15.2 Alliance Healthcare Business Overview
11.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.15.4 Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.15.5 Alliance Healthcare Recent Development
11.16 Allergan, Plc.
11.16.1 Allergan, Plc. Company Detail
11.16.2 Allergan, Plc. Business Overview
11.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.16.4 Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.16.5 Allergan, Plc. Recent Development
11.17 Reckitt Benckiser Plc.
11.17.1 Reckitt Benckiser Plc. Company Detail
11.17.2 Reckitt Benckiser Plc. Business Overview
11.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.17.4 Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.17.5 Reckitt Benckiser Plc. Recent Development
11.18 Bausch & Lomb
11.18.1 Bausch & Lomb Company Detail
11.18.2 Bausch & Lomb Business Overview
11.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.18.4 Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.18.5 Bausch & Lomb Recent Development
11.19 AbbVie Inc.
11.19.1 AbbVie Inc. Company Detail
11.19.2 AbbVie Inc. Business Overview
11.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.19.4 AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.19.5 AbbVie Inc. Recent Development
11.20 The Colgate-Palmolive Company
11.20.1 The Colgate-Palmolive Company Company Detail
11.20.2 The Colgate-Palmolive Company Business Overview
11.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.20.4 The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.20.5 The Colgate-Palmolive Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock